Remdesivir has only marginal benefit for moderate COVID-19 patients
The 600-patient analysis found that moderately-ill patients treated with Remdesivir for up to five days had significantly higher…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
EUA
FDA’s EUA benchmarks for COVID-19 vaccines remain ill-defined: GlobalData
Experts feel that COVID-19 vaccines should ideally demonstrate an upsurge in both neutralising antibody titres and cell-mediated…
US FDA revokes EUA for chloroquine and hydroxychloroquine
The known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the…
US FDA warns against co-administration of remdesivir and chloroquine or HCQ
The drug regulator informs that this may reduce the antiviral activity of remdesivir and lessen the effectiveness of COVID-19…
Remdesivir, tocilizumab being considered for ‘restricted use’ on severely ill COVID-19…
Reportedly, some more drugs to be used in combination with hydroxychloroquine may be added to the protocol
US FDA seeks fast review of COVID-19 products: Commissioner Stephen Hahn
Since the onset of the COVID-19 pandemic earlier this year, the FDA has issued a series of temporary emergency approvals ranging…
US FDA issues EUA for remdesivir for COVID-19 treatment
The EUA allows for remdesivir to be distributed in the US and administered intravenously by healthcare providers, as appropriate,…